J&J drops Sedasys automated sedation system: 6 things to know

Johnson & Johnson will no longer sell the Sedasys automated sedation system, according to MarketWatch.

Here are six things to know:

1. The Sedasys system automated the process of sedating patients prior to colon-cancer screenings.

2. The FDA approved the system in 2013, and it was initially considered an innovative, cost-saving new technology.

3. The sale and marketing of the system saw tremendous pushback from anesthesiologists who claimed that automating the sedation process could lead to patient safety issues.

4. Johnson & Johnson decided to stop selling the system as part of a broader restructuring of its medical device business.

5. According to a company insider, sales of the Sedasys system did not take off as J&J had expected.

6. The company announced the restructuring plan in January, which also includes the proposed elimination of about 3,000 jobs in the medical devices division.

More articles on anesthesia:
Top 5 highest & lowest paying states for anesthesiologists
Surgical, general anesthesia does not cause significant long-term cognitive decline: 4 points
Sheridan Healthcare, Candescent expand partnership to South Florida radiology practice: 5 key notes

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months